PharmaNet hires vp for clinical operations

Catherine Derasp will oversee Phase I clinics

Catherine Derasp has joined PharmaNet Development Group, a US provider of clinical development services to the pharmaceutical and biotechnology industry, as vice president, clinical operations of the company's Phase I clinics.

Derasp will oversee the management of the company's 350-bed Phase I clinical operations that are located in Montreal and Quebec City, Canada. In addition to first-in-man and proof-of-concept phase I clinical services, she will be responsible for a variety of studies in special populations, cardiac safety testing, and drug-drug interaction studies.

You may also like

Regulatory
Measurement uncertainty explained – Why it matters more than you think

Measurement uncertainty explained – Why it matters more than you think

In regulated environments, where decisions often depend on whether a result passes or fails a defined limit, understanding measurement uncertainty becomes critical
Regulatory
Sanofi expands vaccine manufacturing in Abu Dhabi as NICE backs its diabetes therapy

Sanofi expands vaccine manufacturing in Abu Dhabi as NICE backs its diabetes therapy

Sanofi advances on two fronts: a new Abu Dhabi vaccine innovation centre with AI and mRNA capabilities and UK NICE backing for teplizumab, the first disease-modifying treatment for type 1 diabetes
Manufacturing
RFID brings greater visibility to pharmaceutical supply chains

RFID brings greater visibility to pharmaceutical supply chains

From hospital pharmacies to global distribution networks, RFID is adding a new layer of intelligence to pharmaceutical logistics
Manufacturing
Cogent Skills research exposes specialist skills gaps holding back UK medicines manufacturing SMEs

Cogent Skills research exposes specialist skills gaps holding back UK medicines manufacturing SMEs

The Office for Life Sciences-funded report identifies acute gaps in commercial, R&D and digital competencies, recommending simplified apprenticeships and GMP-ready micro-credentials to support sector growth
Pharmaceutical
MSD partners with Abu Dhabi to explore regional pharma logistics hub in HELM Cluster

MSD partners with Abu Dhabi to explore regional pharma logistics hub in HELM Cluster

The collaboration would strengthen supply chain resilience and accelerate access to innovative therapies across the region, subject to approvals, positioning Abu Dhabi as a secure distribution gateway for global pharma
Regulatory
Pharmaceutical regulatory update 2026: EU, UK, FDA & global changes explained

Pharmaceutical regulatory update 2026: EU, UK, FDA & global changes explained

EU Pharma Legislation overhaul + Global GMP updates (2026)
You need to be a subscriber to read this article.
Click here to find out more.
Regulatory
What Operation TrialBlazer means for CDMOs and CMC strategy

What Operation TrialBlazer means for CDMOs and CMC strategy

The FDA's new framework cuts Phase I data requirements, opens platform manufacturing data reuse and creates a new CRO/CDMO review role as HHS moves to close the gap with China's faster clinical trial pipeline — but how will this affect the pharma sector?
Subscribe now